Qlaris Bio Secures $24M in Series B Funding for Eye Disease Treatment
Key Highlights $24 million Series B funding co-led by Canaan and New Leaf Venture Partners. Funds to support Phase II trials of…
Browsing Tag
abrdn Inc
1 post